Ibandronate Sodium Impurity;1154279-11-4

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com
Product Code:I024024
English Name:Ibandronate Sodium Impurity 24
English Alias:methyl 3-(methyl(pentan-2-yl)amino)propanoate
CAS No.:1154279-11-4
Molecular Formula:C₁₀H₂₁NO₂
Molecular Weight:187.28
High-Purity Reference Standard:Confirmed by HPLC (≥99.0%), NMR (1H, 13C), HRMS, and elemental analysis, suitable for Ibandronate Sodium impurity analysis and quality control.
Stability Assurance:Stable for 36 months at -20℃ under light-protected, sealed storage; degradation rate <0.3% in methanol - water mixture within 6 months.
Quality Control Testing:Used for UPLC-MS/MS detection of Impurity 24 in Ibandronate Sodium API and formulations, controlling content to meet ICH Q3A standards (single impurity limit ≤0.1%).
Process Optimization Research:Monitors impurity formation during Ibandronate Sodium synthesis, reducing generation by >30% by adjusting esterification temperature (e.g., 50 - 60℃) and reaction time.
Method Validation:Serves as a standard for developing impurity detection methods, verifying UPLC resolution (≥3.0) and LOD (0.01 ng/mL).
Ibandronate Sodium, a third-generation bisphosphonate drug, is used to treat osteoporosis, bone metastases from malignant tumors, etc., by inhibiting osteoclast activity to reduce bone resorption. Impurity 24, a process-related impurity in its synthesis, may originate from amination or esterification side reactions of intermediates. Its ester and amino groups may affect drug stability, solubility, and efficacy. With strict impurity control requirements for orthopedic drugs, studying this impurity is crucial for ensuring drug quality.
Detection Technology:UPLC-MS/MS with C18 column (1.7μm) and 0.1% formic acid - acetonitrile gradient elution achieves separation within 6 minutes, with LOD of 0.005 ng/mL for trace impurity analysis.
Formation Mechanism:Formed by nucleophilic substitution of methyl 3-aminopropionate with 2-pentanone under formic acid catalysis; optimizing catalyst dosage and reaction pH inhibits side reactions.
Safety Evaluation:In vitro cytotoxicity shows IC₅₀ of 198.6 μM against MG-63 bone cells (Ibandronate Sodium IC₅₀=10.2 μM), with lower toxicity than the main drug but requiring strict content control. Long-term stability testing is ongoing to monitor degradation under high temperature and humidity conditions.
We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!
WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com
NEW IN STOCK!
The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery!